Pharmacology for the Physical Therapist / edited by Erin E. Jobst, Peter C. Panus, Marieke Kruidering-Hall.Series: McGraw-Hill's AccessPhysiotherapyPublication details: New York, N.Y. : McGraw-Hill Education LLC., c2020Edition: 2nd edDescription: 1 online resource : ill., figs., tablesISBN: 9781259862236 (e-ISBN); 1259862232 (e-ISBN)Subject(s): Pharmacology | Drug TherapyAdditional physical formats: Online version: : Pharmacology for the Physical Therapist. DDC classification: 615.1 LOC classification: RM300NLM classification: QV 4Online resources: Click here to access online Also issued in online and PDF version.
Includes bibliographical references and indexes.
PART I: BASIC PRINCIPLES -- Chapter 1: Introduction -- Chapter 2: Pharmacodynamics -- Chapter 3: Pharmacokinetics and Pharmacogenomics -- PART II: DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM -- Chapter 4: Introduction to Autonomic Pharmacology -- Chapter 5: Drugs Affecting the Cholinergic System -- Chapter 6: Sympathomimetics and Sympatholytics -- Chapter 7: Antihypertensive Drugs -- Chapter 8: Drugs Used in the Treatment of Angina Pectoris -- Chapter 9: Drugs Used in Heart Failure -- Chapter 10: Antiarrhythmic Drugs -- Chapter 11: Drugs Affecting the Blood -- PART III: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM -- Chapter 12: Introduction to the Pharmacology of Central Nervous System Drugs -- Chapter 13: Sedative-Hypnotic Drugs -- Chapter 14: Antiseizure Drugs -- Chapter 15: General Anesthetics -- Chapter 16: Local Anesthetics -- Chapter 17: Pharmacologic Management of Parkinson’s Disease and Other Movement Disorders -- Chapter 18: Antipsychotic Agents and Lithium -- Chapter 19: Antidepressant Agents -- Chapter 20: Opioid Analgesics and Antagonists -- Chapter 21: Drugs of Abuse -- PART IV: SELECTED TOPICS IN ENDOCRINE FUNCTION -- Chapter 22: Growth, Thyroid, and Gonadal Pharmacology -- Chapter 23: Corticosteroids and Corticosteroid Antagonists -- Chapter 24: Pancreatic Hormones and Antidiabetic Drugs -- Chapter 25: Drugs that Affect Bone Mineral Homeostasis -- Chapter 26: Antihyperlipidemic Drugs -- PART V: CHEMOTHERAPEUTICS -- Chapter 27: Antibacterial Agents -- Chapter 28: Antiviral Agents -- Chapter 29: Antifungal and Antiparasitic Agents -- Chapter 30: Miscellaneous Antimicrobial Agents: Disinfectants, Antiseptics, Sterilants, and Preservatives -- Chapter 31: Cancer Chemotherapy -- Chapter 32: Immunopharmacology -- PART VI: DRUGS AFFECTING THE MUSCULOSKELETAL SYSTEM -- Chapter 33: Skeletal Muscle Relaxants -- Chapter 34: Drugs Affecting Eicosanoid Metabolism, Disease-Modifying Antirheumatic Drugs, and Drugs Used in Gout -- PART VII: SPECIAL TOPICS -- Chapter 35: Drugs Affecting the Respiratory System -- Chapter 36: Drugs Used in Gastrointestinal Disorders.
According to the Patient-Centered Primary Care Collaborative, medications are involved in approximately 80% of all treatments and impact every aspect of a patient's life. Understanding how the effects of drugs may influence the outcome measures and interventions provided by physical therapists provided the impetus for the first edition of this textbook more than 10 years ago. For example, therapists perform comprehensive assessments of the visual, vestibular, and proprioceptive inputs that control balance to predict an individual's risk of falling. However, this prediction will fall short if the therapist fails to inquire what medications the patient is taking, as many medications—both prescription and over-the-counter—negatively affect balance.
Also issued in online and PDF version.
Description based on cover image and table of contents, viewed on Dec. 09, 2019.